Understanding Patient Perspectives on Radiation Tattoos Authors: Bonnie Hu, Anurag Saraf, Andrew Johnson, Hope Heldreth, Idalid Franco, Brenda Lormil, Jason A Efstathiou, Florence K Keane, Ariel Hirsch, Rachel B Jimenez Published: 2026 ABSTRACT AbstractPurposeThe standard of care for patients undergoing radiation therapy (RT) is to receive permanent, skin-based tattoos to assist with treatment alignment. Prior studies suggest that tattoos can generate emotional distress in patients with cancer, adding to the burden of cancer treatment and recovery. We surveyed patients who received tattoos for RT to understand their perspectives and attitudes toward tattoos.Methods and MaterialsWe conducted a cross-sectional survey of patients who previously received RT at either Massachusetts General Hospital or Boston Medical Center and returned for routine clinical follow-up between May and November 2021. They were asked to complete a 16-item survey that queried patients’ understanding of the purpose of tattoos and the level of distress experienced from receiving tattoos.ResultsThree hundred patients with radiation tattoos completed the survey. The median age was 68 years, 48% were women, and 81% were White; 39% and 46% were diagnosed with breast and genitourinary cancers, respectively. Overall, 20% of patients experienced distress from tattoos. Younger age (49% age <50 years vs 25% age 50-64 years vs 11% age ≥65 years) and not understanding the purpose of tattoos were independently associated with experiencing distress (p < .001 and p = .043, respectively). Furthermore, younger age, a primary language other than English, being unaware they would receive tattoos, and a lack of understanding of the purpose of tattoos were also associated with continued or increased distress. Notably, one-quarter of patients indicated that they were unaware they would be receiving tattoos prior to radiation planning.ConclusionsReceiving radiation tattoos is a source of distress for a sizable minority of patients receiving RT for cancer. Young patients and those lacking understanding of the purpose of tattoos were most likely to experience distress. Future interventions should address both patient education and the elimination of permanent tattoos for RT, as appropriate. Introduction Administration of tattoos remains a standard procedure for patients undergoing radiation therapy (RT). Tattoos aid in the planning and alignment process, ensuring patients receive accurate and precise treatment. Tattoos are typically small, around 2 to 3 mm (about 0.12 in) in size, and resemble a freckle or other natural skin marking.1 However, they can cause distress in patients, serving as a permanent reminder of their cancer diagnosis. Furthermore, patients express concerns with receiving tattoos due to pain, religious reasons, and other body image concerns.2, 3, 4, 5 To date, few studies have examined the psychological impact of radiation tattoos on patients, and those studies have been limited to specific populations, including young women with breast cancer and patients receiving palliative radiation, preventing generalizability and an understanding of the proportion of patients receiving RT who experience distress from radiation tattoos.3,6, 7, 8 Furthermore, alternatives to permanent radiation tattoos, including UV-fluorescent ink tattoos and semipermanent markings, have yielded results comparable to those of permanent radiation tattoos in terms of treatment setup accuracy.9, 10, 11 These studies, combined with the recent implementation of 3-dimensional surface imaging, have called into question the utility of permanent tattoos for treatment alignment and positioning. Several single-institutional studies have highlighted comparable, and in some cases better, accuracy than alternatives, including 3-dimensional surface imaging.9,12, 13, 14, 15, 16, 17 However, the adoption of mark-free patient setups for daily treatment alignment is not widespread. Therefore, understanding patients’ distress and perspectives on receiving radiation tattoos is critical for identifying patient concerns, enhancing patient education, and targeting the groups most interested in a tattoo-free RT approach. We sought to understand a diverse patient population’s experiences with radiation tattoos across 2 academic centers, focusing on radiation tattoo-induced distress as the primary outcome. Methods and Materials Study population We conducted a cross-sectional survey of patients who had previously received RT at either Massachusetts General Hospital or Boston Medical Center to understand their perspectives on receiving tattoos during radiation treatment. Surveys were distributed to all eligible patients who received RT and returned for follow-up between May and November 2021, irrespective of cancer type. Patients who spoke English, Spanish, or Haitian Creole were eligible to participate in the study. Surveys were distributed to patients by clinicians during appointments. The study was approved by the institutional review boards of Massachusetts General Hospital and Boston Medical Center. Survey development Survey questions were developed by a multidisciplinary team comprising radiation oncologists and oncology nurse practitioners with expertise in caring for patients across multiple cancer sites. The survey was developed in English, then translated into Spanish and Haitian Creole, and validated by native speakers. The survey was further piloted by 6 independent radiation oncologists and advanced practice providers with expertise in radiation oncology to refine its comprehension and clarity. The final survey included 16 items, 6 demographic questions, and 10 questions exploring the patient’s experience with receiving radiation tattoos, including inquiries regarding whether the patient understood the purpose of tattoos, their level of distress related to tattoo placement (if any), the nature of any distress, and the level of ongoing distress (if any) related to the permanent presence of the tattoos. Specifically, patients were asked to recall their level of distress at the time they received tattoos and to report on current distress levels associated with having tattoos after completion of RT. Questions included “yes/no,” multiple-choice, and Likert scale-based responses (see Supplement for the complete survey and survey instructions are available as Supplementary Materials). All responses were anonymous and deidentified. Statistical analysis Descriptive statistics were conducted for demographic and clinical variables. Baseline clinical characteristics were summarized using medians and IQRs for continuous variables and counts and percentages for categorical variables. The primary question of interest was patient-reported outcomes on the level of distress experienced upon receiving radiation tattoos. The level of distress was assessed using a 5-point Likert scale with ordinal responses: (1) not at all, (2) slightly, (3) moderately, (4) very, and (5) extremely. Baseline distress and posttreatment distress were analyzed in 2 ways: by grouping patients who reported any distress and by grouping patients who reported high distress. Analysis of any distress was dichotomized into no distress (score = 1) or any distress (score = 2-5); analysis of high distress was dichotomized into low distress (score = 1-3) or high distress (score = 4-5). Stable or increased distress was defined as no change or an increase in the distress score if patients had an initial distress score of 2 to 5, or an increase in the distress score if patients had an initial distress score of 1 and reported increasing distress after initial tattoo placement. Associations between distress and baseline characteristics were evaluated using logistic regression. Characteristics significantly associated with any distress or high distress were included in the multivariable analysis. Statistical analyses were performed with Stata version 17.0 (StataCorp LLC). P values < .05 were considered statistically significant. Results A total of 419 responses were collected, of which 337 (80%) reported having received tattoos. Of the 337 patients who received tattoos, 300 (89%) provided complete responses regarding age, sex, and the level of distress experienced from receiving tattoos. Of the 300 patients included in our final sample, 251 (84%) were treated at Massachusetts General Hospital, and 49 (16%) received RT at Boston Medical Center (Table 1). The median age of respondents was 68 years (IQR, 59-74). Approximately half (48%) of the respondents identified as women, 81% as White, 9% as Black, 4% as Asian, 0.3% as American Indian or Alaska Native, 2% as multiple races, and 4% as a different race. Six percent identified as Hispanic or Latino. English was the primary language spoken by 97% of respondents, with 2% speaking Spanish and 0.3% speaking Haitian Creole. Of the 300 patients in our sample, 46% had a genitourinary (GU) cancer diagnosis, 39% had breast cancer, 4% had gynecologic and thoracic cancer, 2% each had gastrointestinal, head and neck, and sarcoma cancer, 1% each had central nervous system and hematologic malignancies, and 2% had a different cancer type. Over one-third (37%) of respondents completed radiation within the last year, 33% between 1 and 3 years ago, and 30% more than 3 years ago. A small proportion (13%) of respondents endorsed having cosmetic tattoos unrelated to their radiation tattoos at the time of survey completion. Table 1Patient demographicsTable 1 dummy alt textCharacteristicN = (%)Institutionn = 300 149 (16.3) 2251 (83.7)Age (y)n = 300 Mean (range)65.3 (19-89) Median (IQR)68 (59-74)Sexn = 300 Women143 (47.7) Men157 (52.3)Racen = 293 White236 (80.5) Black26 (8.9) Asian11 (3.8) American Indian/Alaska Native1 (0.3) Native Hawaiian/Pacific Islander0 Multiple races5 (1.7) Other14 (4.8)Latinon = 292 Yes18 (6.2)Primary language spokenn = 300 English292 (97.3) Spanish7 (2.3) Haitian Creole1 (0.3)Cancer type*n = 300 Breast118 (39.3) CNS4 (1.3) GU139 (46.3) GI5 (1.7) GYN12 (4.0) Head and neck5 (1.7) Heme/lymphoma2 (0.7) Lung11 (3.7) Sarcoma5 (1.7) Other7 (2.3)Radiation complete?n = 293 ≤1 y ago108 (36.9) 1-3 y ago97 (33.1) >3 y ago88 (30.0)Data are presented as n (%).Abbreviations: CNS = central nervous system; GI = gastrointestinal; GU = genitourinary; GYN = gynecologic.⁎Eight patients had more than 1 cancer diagnosis. Patient demographics Data are presented as n (%). Abbreviations: CNS = central nervous system; GI = gastrointestinal; GU = genitourinary; GYN = gynecologic. Eight patients had more than 1 cancer diagnosis. Patient experiences with radiation tattoos Of the 300 respondents with complete data, 25% (n = 74) reported being unaware they would receive tattoos prior to radiation treatment planning; however, most (271/300, 90%) reported understanding the purpose of tattoos. Patients who did not understand the purpose of tattoos prior to undergoing radiation planning were more likely to find tattoos distressing (33% vs 17%; p = .016). In all, approximately one-fifth (n = 59, 20%) reported experiencing some distress (a score of 2-5 on a 5-point Likert scale; see Supplementary material for survey measures) from receiving tattoos at any point. Specifically, 11% (n = 32) reported slight distress, 5% (n = 15) moderate distress, 2% (n = 6) significant (“very”) distress, and 1% (n = 4) extreme distress. Two (<1%) patients endorsed distress, but did not provide a distress level. Younger patients (age <50 years) were more likely to report any level of tattoo-induced distress compared with older patients (49% age <50 years vs 25% age 50-64 years; p = .027) (49% age <50 years vs 11% age ≥65 years; p < .001) (Table 2). In univariate analysis, a greater proportion of women experienced distress from receiving tattoos compared with men (32% vs 9%; p < .001). Notably, over one-third (34%) of patients with breast cancer reported greater distress from radiation tattoos compared with 10% of patients with nonbreast diagnoses (p < .001). Furthermore, 7% of patients receiving treatment for GU cancer experienced distress compared with 30% of patients with a non-GU diagnosis (p < .001). Non-White race (29% vs 17%; p = .037), a primary language other than English (50% vs 19%; p = .043), completion of radiation in the last year (27% <1 year vs 16% 1-3 year[s]; p = .05) (27% <1 year vs 15% >3 years; p = .043), and not understanding the purpose of radiation tattoos (33% did not understand vs 46% unsure vs 17% understood; p = .013) were also associated with distress from tattoo placement. In the multivariable model (Table 3), younger age, recent radiation exposure, and not understanding the purpose of radiation tattoos were independently associated with distress. With respect to the intensity of distress in multivariable analysis, younger age (p = .008) and being unaware they would receive tattoos at the time of radiation planning (p = .006) were associated with higher levels of distress, independent of sex, race, primary language spoken, understanding the purpose of tattoos, and cancer diagnosis. Table 2Univariable analysis of any distress (score 2-5/5) about receiving tattoos by patient and disease characteristicsTable 2a dummy alt textOverall respondents N = 300, n (%)No distress n = 241, n%Any distress n = 59, n%Univariable OR (95% CI), p valueAge (y) <50 50-64 >6533 (11.0)89 (29.7)178 (59.3)176515951.575.588.816241948.524.511.2Ref.0.39 (0.17-0.90), .0270.13 (0.06-0.29), <.001Sex Women Men143 (47.7)157 (52.3)9814368.591.1451431.58.9Ref.0.21 (0.11-0.41), <.001Race White Other234 (78.0)66 (22.0)1944782.971.2401917.128.8Ref.1.96 (1.03-3.69), .037Primary language English Other292 (97.3)8 (2.7)237481.250.055418.850.0Ref.4.35 (1.04-16.6), .043Institution 1 2251 (83.7)49 (16.3)2023980.579.6491019.520.4Ref.1.06 (0.49-2.26), .886RT <1 y 1-3 y >3 y Unknown108 (36.0)97 (32.3)88 (29.3)7 (2.3)798275573.284.585.271.4291513226.915.514.828.6Ref.0.50 (0.25-0.99), .0500.47 (0.23-0.98), .043-Tattoo history No cosmetic tattoo Cosmetic tattoo Unknown251 (83.7)39 (13.0)10 (3.3)20034779.787.270.0515320.312.830.0Ref.0.58 (0.21-1.55), .275-Awareness of receiving tattoos Not aware Aware Blank74 (24.7)220 (73.3)6 (2.0)57179577.081.483.31741123.018.616.7Ref.0.77 (0.41-1.46), .418-Purpose of tattoos Understand purpose Did not understand Not sure Blank271 (90.3)9 (3.0)13 (4.3)7 (2.3)22567383.066.753.942.94636417.033.346.257.1Ref.2.45 (0.59-10.1), .2184.19 (1.34-13.1), .013-Cancer type Nonbreast Breast182 (60.7)118 (39.3)1637889.666.1194010.433.9Ref.4.40 (2.39-8.09), <.001 Non-GU GU161 (53.7)139 (46.3)11212969.692.8491030.47.2Ref.0.18 (0.09-0.37), <.001Breast/GU Nonbreast/non-GU256 (85.3)44 (14.7)2063580.579.650919.520.5Ref.1.06 (0.48-2.35), .887Abbreviations: GU = genitourinary; OR = odds ratio; Ref. = reference; RT = radiation therapy. Univariable analysis of any distress (score 2-5/5) about receiving tattoos by patient and disease characteristics Abbreviations: GU = genitourinary; OR = odds ratio; Ref. = reference; RT = radiation therapy. Table 3Multivariable analysis of any distress (score 2-5/5) about receiving tattoos by patient and disease characteristicsTable 2b dummy alt textOverall Respondents N = 300, n (%)No distressn = 241, n%Any distress n = 59, n%Multivariable OR (95% CI), p valueAge <50 50-64 >6533 (11.0)89 (29.7)178 (59.3)176515951.575.588.816241948.524.511.2Ref.0.33 (0.13-0.85), .0210.14 (0.05-0.37), <.001Sex Women Men143 (47.7)157 (52.3)9814368.591.1451431.58.9Ref.1.04 (0.20-5.40), .963Race White Other234 (78.0)66 (22.0)1944782.971.2401917.128.8Ref.0.75 (0.30-1.84), .525Primary language English Other292 (97.3)8 (2.7)237481.250.055418.850.0Ref.3.34 (0.47-25.0), .231RT <1 y 1-3 y >3 y Unknown108 (36.0)97 (32.3)88 (29.3)7 (2.3)798275573.284.585.271.4291513226.915.514.828.6Ref.0.42 (0.18-0.96), .0390.81 (0.34-1.89), .619-Purpose of tattoos Understand purpose Did not understand Not sure Blank271 (90.3)9 (3.0)13 (4.3)7 (2.3)22567383.066.753.942.94636417.033.346.257.1Ref.3.72 (0.52-26.76), .1924.25 (1.10-16.49), .036-Cancer type Nonbreast Breast182 (60.7)118 (39.3)1637889.666.1194010.433.9Ref.2.16 (0.64-7.33), .214 Non-GU GU161 (53.7)139 (46.3)11212969.692.8491030.47.2Ref.0.52 (0.12-2.22), .512Abbreviations: GU = genitourinary; OR = odds ratio; Ref. = reference; RT = radiation therapy. Multivariable analysis of any distress (score 2-5/5) about receiving tattoos by patient and disease characteristics Abbreviations: GU = genitourinary; OR = odds ratio; Ref. = reference; RT = radiation therapy. Following the completion of RT, fewer patients (n = 34, 11%) reported ongoing distress from tattoos. Among those who reported ongoing distress after RT, younger age, a lack of awareness that they would receive tattoos, and not understanding the purpose of tattoos were all associated with distress, all p < .05 in MVA (Supplemental Table a and b). Compared with baseline distress levels, a small proportion of patients across all age groups reported an increase in distress (6% age <50 years vs 6% age 50-65 years vs 4% age >65 years) (Fig. 1). In multivariable analysis, a primary language other than English (p = .009), unawareness of receiving tattoos (p = .041), and not understanding the purpose of tattoos (p = .029) were independently associated with continued or increased distress. Change in distress before and after receiving radiation tattoos with respect to (a) age, (b) awareness of receiving tattoos, and (c) understanding the purpose of tattoos. Nature of distress caused by radiation tattoos Of the 59 patients who reported distress, 51 (86%) chose to describe the nature of their distress. The survey allowed respondents to select multiple reasons. The most frequently noted reasons included an unwanted or uncontrolled change to the body (n = 22, 43%), pain experienced from tattoos (n = 17, 33%), feeling opposed to tattoos (n = 10, 20%), and concern about scar formation (n = 6, 12%) (Fig. 2). Following completion of therapy, 34 patients reported distress, of which 31 (91%) described the nature of their ongoing distress. The most frequently noted reasons included 20 patients (65%) who indicated that tattoos were a reminder of their diagnosis to themselves or others, 13 (38%) who did not like the way they looked, and 8 (26%) who reported feeling opposed to tattoos. Nature of distress caused by radiation tattoos. Patient perspectives on radiation tattoos While few patients (n = 13, 4%) considered having their radiation tattoos removed, 8% (n = 24) reported they would be more satisfied with their radiation treatment if it did not require tattoos, and 16% (n = 46) were unsure. Of the 24 patients who would be more satisfied with tattoo-free radiation, 83% (n = 20) were <65 years old, and 79% (n = 19) were women. Over one-quarter (n = 78, 27%) of respondents believed that other patients would be more satisfied with their treatment experience if technology enabled the safe delivery of radiation without the need for tattoos. Nearly half (n = 129, 45%) were unsure whether tattoo-free radiation treatment would improve patient satisfaction with care, while 28% (n = 82) did not believe such changes would increase satisfaction. Discussion In this study, we found that approximately 20% of patients reported some level of distress from receiving tattoos for RT. While the level of distress was generally mild, the highest distress levels were among young patients and those who were unaware they would be receiving tattoos prior to treatment planning. These results point to the impact that radiation tattoos may have on the quality of life of younger patients receiving radiation treatment. The majority of younger patients in our study had breast cancer, and this group has been previously identified as having negative associations with radiation tattoos. In a survey of 142 breast cancer survivors from the Young Survival Coalition, nearly 70% of respondents harbored negative sentiments toward receiving tattoos, and 78% preferred avoiding tattoos, even if it meant sacrificing money or time to seek such care.6 This distress may be due, in part, to the location of tattoos on the chest, where they are more visible. However, our results further suggest that young patients across cancer types may be susceptible to distress from tattoo placement and that alternatives for these patients should be considered. There is an increasing body of literature on the use of surface image guidance instead of permanent tattoo placement.7,8,13, 14, 15,17 As these technologies become widely used, there is an opportunity for centers to move away from permanent tattoo placement entirely. In addition, in our study, a substantial proportion of respondents noted that they were unaware they would be receiving tattoos before undergoing radiation treatment planning. These patients, as well as those who reported a lack of understanding regarding the purpose of tattoos, and those who spoke a language other than English, all experienced more ongoing distress from tattoo placement. These findings highlight the importance of enhanced patient education regarding tattoo placement prior to radiation planning to engage patients and limit distress. These are also reassuring, as they represent modifiable factors that physicians and care teams can intervene in to mitigate patient distress. For example, providing clinicians with a consent checklist that includes a discussion of tattoo placement may help remind providers to communicate this to patients. Additionally, providing the patient with written materials in their native language and/or using formal interpreter services during these discussions may enhance the patient’s knowledge and preparation for tattoo placement. To our knowledge, this survey study presents the largest and most comprehensive sample of patients’ experiences and perspectives on receiving radiation tattoos. Our study includes patients who were seen for follow-up of various cancer diagnoses at 2 institutions. However, there are several limitations. The cross-sectional nature of the survey limits patient responses to a single time point following the completion of radiation. As patients were surveyed only after receiving radiation tattoos, patients’ reporting may be subject to recall bias, and survey responses may fail to fully capture the nuances of the nature of distress, including how distress severity may fluctuate during and after radiation. Moreover, our study had a modest event rate, which renders the multivariable analysis more exploratory than definitive. Additionally, the patient population is a convenience sample and therefore comprises a large proportion of patients seen for breast or GU diagnoses, which may limit the generalizability of broader conclusions to other disease sites. Similarly, because surveys were distributed by clinicians in the clinic, we were unable to determine the number of patients approached to calculate a reliable response rate; therefore, the survey is subject to response bias. Furthermore, although our survey was conducted at 2 institutions, our patient sample is primarily White and non-Latino, with English as the primary language spoken. Finally, a sizable minority of survey respondents who received tattoos did not complete all demographic survey questions and were excluded from the final analysis. An author review of their responses indicated distress rates similar to those of patients with complete data, but it is possible that bias was introduced by their exclusion. Conclusions Approximately 1 in 5 patients experiences distress from the placement of radiation tattoos. This study identified several factors associated with distress and provides valuable insights into the patient experience. Consideration should be given to increasing awareness and understanding of the use and purpose of tattoos to mitigate the psychological impact of permanent skin markings, and to implementing tattoo-free patient setups at centers where the technology is available. Disclosures The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Footnotes Sources of support: This work had no specific funding. Data Sharing Statement: Research data are stored in an institutional repository and will be shared upon request to the corresponding author. Supplementary material associated with this article can be found in the online version at doi:10.1016/j.adro.2026.102095. Supplementary materials mmc1.docx mmc2.docx References Associated Data Supplementary Materials mmc1.docx mmc2.docx